SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-060282
Filing Date
2021-05-03
Accepted
2021-05-03 16:52:00
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2114499d1_s3.htm S-3 676391
2 EXHIBIT 4.4 tm2114499d1_ex4-4.htm EX-4.4 450584
3 EXHIBIT 5.1(A) tm2114499d1_ex5-1a.htm EX-5.1(A) 25152
4 EXHIBIT 5.1(B) tm2114499d1_ex5-1b.htm EX-5.1(B) 31841
5 EXHIBIT 23.1 tm2114499d1_ex23-1.htm EX-23.1 3996
6 GRAPHIC tm2114499d1_s3img001.jpg GRAPHIC 9515
7 GRAPHIC tm2114499d1_5-1aimg001.jpg GRAPHIC 7287
  Complete submission text file 0001104659-21-060282.txt   1212719
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255726 | Film No.: 21884315
SIC: 2834 Pharmaceutical Preparations